MedPath

SODIUM SULFACETAMIDE

SODIUM SULFACETAMIDE 10% WASHRx OnlyFOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Approved
Approval ID

ba08bf7c-5fdc-447a-b8de-3f319cee7e4e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 12, 2023

Manufacturers
FDA

Akron Pharma Inc

DUNS: 067878881

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM SULFACETAMIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71399-0480
Product Classification
G
Generic Name
SODIUM SULFACETAMIDE
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 12, 2023
FDA Product Classification

INGREDIENTS (16)

CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SULFACETAMIDE SODIUMActive
Quantity: 100 mg in 1 mL
Code: 4NRT660KJQ
Classification: ACTIB
COCAMIDOPROPYL BETAINEInactive
Code: 5OCF3O11KX
Classification: IACT
GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PEG-6 CAPRYLIC/CAPRIC GLYCERIDESInactive
Code: GO50W2HWO8
Classification: IACT
PEG-60 ALMOND GLYCERIDESInactive
Code: 4Y0E651N0F
Classification: IACT
EDETATE DISODIUM ANHYDROUSInactive
Code: 8NLQ36F6MM
Classification: IACT
PEG-150 PENTAERYTHRITYL TETRASTEARATEInactive
Code: 8L4OOQ76AM
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SODIUM THIOSULFATEInactive
Code: HX1032V43M
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM SULFACETAMIDE - FDA Drug Approval Details